CSL830

BIOLOGICAL2 trials

Sponsors

CSL Behring, Joshua S. Jacobs, MD

Conditions

Hereditary Angioedema Types I and II

Phase 1

A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor

CompletedNCT01760343

CSL BehringHereditary Angioedema Types I and II

Start: 2013-01-31End: 2013-03-31Updated: 2013-04-05

Unknown Phase

Expanded Access for Hereditary Angioedema (HAE)

Joshua S. Jacobs, MD

Updated: 2024-02-07